Cancer cell metabolism is deregulated, and signalling pathways can be involved. For instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its alteration is detectable in cancer cells, that exploit the normal mechanisms to overcome apoptosis. On the other hand, also the family of Phospholipase C (PLC) enzymes play a critical role in cell growth, and any change concerning these enzymes or their downstream targets can be associated with neoplastic transformation. Here, we review the role of PLC and PI3K/Akt/mTOR signal transduction pathways in pathophysiology.
Follo, M.Y., Manzoli, L., Poli, A., Mccubrey, J.A., Cocco, L. (2015). PLC and PI3K/Akt/mTOR signalling in disease and cancer. ADVANCES IN BIOLOGICAL REGULATION, 57, 10-16 [10.1016/j.jbior.2014.10.004].
PLC and PI3K/Akt/mTOR signalling in disease and cancer
FOLLO, MATILDE YUNG;MANZOLI, LUCIA;POLI, ALESSANDRO;COCCO, LUCIO ILDEBRANDO
2015
Abstract
Cancer cell metabolism is deregulated, and signalling pathways can be involved. For instance, PI3K/Akt/mTOR is associated with normal proliferation and differentiation, and its alteration is detectable in cancer cells, that exploit the normal mechanisms to overcome apoptosis. On the other hand, also the family of Phospholipase C (PLC) enzymes play a critical role in cell growth, and any change concerning these enzymes or their downstream targets can be associated with neoplastic transformation. Here, we review the role of PLC and PI3K/Akt/mTOR signal transduction pathways in pathophysiology.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
